Abstract

Management of Localized-Stage Follicular Lymphoma: Changing the Paradigm?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Minimal residual disease - ready for prime time in follicular lymphoma?
Laura Magnano ... Armando López‐Guillermo
British journal of haematology | VOL. 188
Laura Magnano, et. al.Laura Magnano ... Armando López‐Guillermo
31 Jul 2019
Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: Results of a pilot study
Bosco Chacon ... Pierre Soubeyran
International Journal of Radiation Oncology, Biology, Physics | VOL. 40
Bosco Chacon, et. al.Bosco Chacon ... Pierre Soubeyran
01 Jan 1998
Imaging Follicular Lymphoma Using Positron Emission Tomography With [18F]Fluorodeoxyglucose: To What Purpose?
Sally F Barrington ... N George Mikhaeel
Journal of Clinical Oncology | VOL. 30
Sally F Barrington, et. al.Sally F Barrington ... N George Mikhaeel
29 Oct 2012
MINIMAL RESIDUAL DISEASE (MRD) IN EARLY STAGE FOLLICULAR LYMPHOMA CAN PREDICT PROGNOSIS AND DRIVE RITUXIMAB TREATMENT AFTER RADIOTHERAPY
L.A De Novi ... A Guarini
Hematological Oncology | VOL. 35
L.A De Novi, et. al.L.A De Novi ... A Guarini
01 Jun 2017
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers